Antares Pharma Inc (NASDAQ:ATRS)

4.36
Delayed Data
As of Jul 23
 +0.02 / +0.46%
Today’s Change
2.55
Today|||52-Week Range
5.07
+9.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues45.7M52.2M54.5M63.6M
 
 
 
 
 
Cost of Goods Sold18.4M27.5M25.9M28.9M
 
 
 
 
 
Depreciation And Amortization1.6M1.9M2.1M2.7M
 
 
 
 
 
 
Operating ExpensesGross Income25.7M22.9M26.5M31.9M
 
 
 
 
 
General Expenses46.1M47.0M42.9M48.5M
 
 
 
 
 
Research And Development19.7M21.1M13.1M12.3M
 
 
 
 
 
Total Operating Expenses66.1M76.3M71.0M80.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.5M-24.1M-16.5M-16.6M
 
 
 
 
 
Extraordinary Charge-31.5K0.00-46.0K0.00
 
 
 
Interest Expense On Debt0.000.001.4M2.7M
 
 
 
Other Expenses-50.8K-202.1K1.2M12.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.5M-24.2M-16.7M-6.5M
 
 
 
 
 
Income Taxes-175.0K-100.0K0.000.00
 
 
 
Net Income-20.7M-24.3M-16.7M-6.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS146.6M155.0M156.1M157.4M
 
 
 
 
 
Shares To Calculate EPS Diluted146.6M155.0M156.1M157.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14-$0.16-$0.11-$0.04
 
 
 
 
 
EPS Diluted-$0.14-$0.16-$0.11-$0.04